Wealth Enhancement Advisory Services LLC Has $2.65 Million Holdings in The Cooper Companies, Inc. $COO

Wealth Enhancement Advisory Services LLC lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 212.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,455 shares of the medical device company’s stock after purchasing an additional 21,383 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Cooper Companies were worth $2,652,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in COO. Buckhead Capital Management LLC boosted its stake in shares of Cooper Companies by 14.3% during the 3rd quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock worth $4,040,000 after buying an additional 7,368 shares during the last quarter. First American Bank acquired a new stake in shares of Cooper Companies in the third quarter valued at about $1,646,000. JANA Partners Management LP acquired a new stake in shares of Cooper Companies in the third quarter valued at about $166,917,000. Rakuten Investment Management Inc. bought a new stake in Cooper Companies during the third quarter worth about $11,341,000. Finally, Amundi raised its holdings in Cooper Companies by 35.5% during the second quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock worth $97,225,000 after acquiring an additional 348,652 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $71.43 on Thursday. The stock has a market capitalization of $13.94 billion, a PE ratio of 35.36, a P/E/G ratio of 1.84 and a beta of 1.02. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The business has a fifty day moving average price of $78.15 and a two-hundred day moving average price of $76.23. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the prior year, the business posted $0.92 earnings per share. Cooper Companies’s revenue was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

COO has been the subject of a number of analyst reports. Citigroup decreased their price target on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research note on Friday, March 6th. Wells Fargo & Company increased their price objective on Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a report on Friday, December 5th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. Finally, William Blair upgraded Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.